Publications

Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.

Mikulak J

Retrovirology. 2016 Sep 6;13(1):63. doi: 10.1186/s12977-016-0296-3

Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.

Hudspeth K

J Autoimmun. 2015 Aug 30;66:40-50. doi: 10.1016/j.jaut.2015.08.011

Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.

Donadon M

J Gastrointest Surg. 2017 May 23;21(8):1226-1236. doi: 10.1007/s11605-017-3446-6

Increased Frequency and Vasculogenic Potential of Endothelial Colony-Forming Cells in Patients with Kaposi’s Sarcoma.

Calcaterra F

J Invest Dermatol. 2017 Mar 10;137(7):1533-1540. doi: 10.1016/j.jid.2017.02.979

The early expansion of anergic NKG2A(pos)/CD56(dim)/CD16(neg) natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.

Roberto A

Haematologica. 2018 Apr 26;103(8):1390-1402. doi: 10.3324/haematol.2017.186619

Chemotherapy accelerates immune-senescence and functional impairments of Vδ2(pos) T cells in elderly patients affected by liver metastatic colorectal cancer.

Bruni E

J Immunother Cancer. 2019 Dec 11;7(1):347. doi: 10.1186/s40425-019-0825-4

NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.

Mikulak J

JCI Insight. 2019 Dec 19;4(24)pii: 125884. doi: 10.1172/jci.insight.125884

HIV-1-induced inflammation shapes innate immunity and induces adaptive traits in NK cells.

Mikulak J, Di Vito C, Mavilio D

Nat Immunol. 21(3):245-247. doi: 10.1038/s41590-020-0615-7

Pathologic up-regulation of TNFSF15-TNFRSF25 axis sustains endothelial dysfunction in unprovoked venous thromboembolism.

Della Bella S

Cardiovasc Res. 116(3):698-707. doi: 10.1093/cvr/cvz131

Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.

Mariotti J

Blood Adv. 4(16):3900-3912. doi: 10.1182/bloodadvances.2020001620